Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person3
Kolchinsky Peter
Company
Chin Peter Scott
Company
KASH PETER M
Company
Primary record20
RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A
(the "SEC") on February 9, 2018, and amended on July 30, 2019, December 16, 2020, March 23, 2021, September 6, 2022, October 4, 2022, December 5, 2022, January 11, 2024, June 12, 2024, February 21, 2025, August 14, 2025,
LENZ Therapeutics, Inc. filed SCHEDULE 13D/A
(the "SEC") on March 28, 2024 and amended on May 9, 2025 and November 7, 2025 (as amended, the "Statement") by the Reporting Persons. Unless otherwise defined herein, capitalized terms used in this Amendment No. 3 shall
Kolchinsky Peter filed 4
SEC form 4 filed by Kolchinsky Peter (CIK 1384859) on 2026-11-02.
RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G
(the "SEC") on October 16, 2026. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting P
Alector, Inc. filed SCHEDULE 13G
(the "SEC") on August 6, 2026 and (ii) 36,600,000 shares of common stock issued in the Issuer's public offering of equity securities that closed on October 19, 2026, as reported in the Issuer's Current Report on Form 8-K
Frazier Life Sciences Acquisition Corp. II filed SCHEDULE 13G
(the "SEC") on October 14, 2026. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting P
Kolchinsky Peter filed 4
SEC form 4 filed by Kolchinsky Peter (CIK 1384859) on 2026-10-07.
Kolchinsky Peter filed 4
SEC form 4 filed by Kolchinsky Peter (CIK 1384859) on 2026-10-05.
Corbus Pharmaceuticals Holdings, Inc. filed SCHEDULE 13G
(the "SEC") on August 4, 2026. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Per
BetterLife Pharma Inc. filed SCHEDULE 13G
0001346824-26-000241.txt : 20260922 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001346824 XXXXXXXX LIVE Common Shares, no par value per share 09/15/2026 0001464165 BetterLife Pharma Inc. 08772P202 1275 West 6th Av
RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A
(the "SEC") on February 18, 2025 and amended on November 7, 2025 (the "Statement") by the Reporting Persons. Unless otherwise defined herein, capitalized terms used in this Amendment No. 2 shall have the meanings ascribe
Kolchinsky Peter filed 4
SEC form 4 filed by Kolchinsky Peter (CIK 1384859) on 2026-09-21.
RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A
(the "SEC") on September 27, 2021, and amended on February 6, 2024, October 22, 2024, November 13, 2024, March 31, 2025, June 6, 2025 and March 6, 2026 (as amended, the "Statement") by the Reporting Persons. Unless other
Kolchinsky Peter filed 4
SEC form 4 filed by Kolchinsky Peter (CIK 1384859) on 2026-09-17.
JATT III Acquisition Corp filed SCHEDULE 13G
(the "SEC") on August 26, 2026. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Pe
Kolchinsky Peter filed 4
SEC form 4 filed by Kolchinsky Peter (CIK 1384859) on 2026-08-26.
Latigo Biotherapeutics, Inc. filed SCHEDULE 13G
(the "SEC") on August 7, 2026. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Per
Avalo Therapeutics, Inc. filed SCHEDULE 13G/A
(the "SEC") on August 6, 2026, and (ii) 2,483,099 shares of common stock issuable upon conversion of the Preferred Stock. Row 5 of each Reporting Person's cover page to this Schedule 13G/A sets forth the sole power to vo
Kolchinsky Peter filed 4
SEC form 4 filed by Kolchinsky Peter (CIK 1384859) on 2026-08-14.
RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A
(the "SEC") on November 4, 2024 (the "Statement") by the Reporting Persons. Unless otherwise defined herein, capitalized terms used in this Amendment No. 1 shall have the meanings ascribed to them in the Statement. Unles